This website is intended for healthcare professionals

News

Prescribing fluoroquinolone: from revolutionary to restricted

In the UK, there are currently five fluoroquinolones licensed for use, which can be taken orally, given intravenously or via inhalation. These include the most common, ciprofloxacin, which is used to...

Antibiotic prescribing

This article, published in the British Journal of Health Psychology, was a systematic review to garner health professionals' knowledge and attitudes of antibiotic prescribing for urinary tract...

Use of genomic medicine to uncover adverse effects related to direct oral anticoagulants

Cardiac arrhythmias represent a significant burden, affecting morbidity and mortality (Gheorghe-Andrei et al, 2018). Atrial fibrillation (AF) is the most common arrhythmia, and prevalence not only...

UPDATES

The Joint Committee on Vaccination and Immunisation (JCVI) has announced its advice to government for the Covid-19 vaccine programme this year.

The importance of communication as a prescriber

‘Prescribers should become aware of the characteristics of the setting in which they work, and be conscious of how this may influence communication and patient interactions’.

Prescribing cascades

This research, published in the Journal of Pharmacoepidemiology and Drug Safety sought to implement a high-throughput signal detection programme using a sequence symmetry analysis to identify...

Updates

A researcher from the University of Glasgow has received funding to develop new wearable technology capable of measuring the progress of neuromuscular diseases. Professor Hadi Heidari has been awarded...

Evolution of the use of quetiapine

Duncan et al (2016) published a study in the BMJ Open, which evaluated trends in the prescribing of quetiapine to adults in the Canadian province of Alberta between 2008 and 2013.

Prescribing in cancer care

This article, published in the Journal of Advanced Nursing, sought to review the evidence surrounding nurse and pharmacist review of patients undergoing systemic anti-cancer therapy (SACT).

Nurse prescribing: a global perspective

This study, published in the Saudi Pharmaceutical Journal, aimed to explore nurses' readiness to prescribe under supervision. It further sought to identify any association between the prescribing...

Medical royal colleges ‘receive millions from drug and medical devices companies’

Royal colleges in the UK have received more than £9 million in marketing payments from drug and medical devices companies since 2015, but do not always disclose the payments publicly, finds an...

The hidden risks of fluoroquinolones

A study published late last year in the British Medical Journal (Wang et al, 2022) evaluated the association between the initiation of fluoroquinolones and admissions to hospitals or emergency...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP